Cingulate Inc. (CING) CEO-linked LLC acquires shares and new warrants
Rhea-AI Filing Summary
Cingulate Inc. director and Chief Executive Officer Shane J. Schaffer reported indirect purchases through Fountainhead Shrugged, LLC. On February 6, 2026, the LLC acquired 6,809 shares of common stock at $5.04 per share, bringing its indirectly held common stock to 10,175 shares, while Schaffer also holds 173 shares directly.
On the same date, Fountainhead Shrugged, LLC acquired warrants for 5,447 shares of common stock at $0.10 per warrant. The filing notes these common shares and warrants were obtained in a private placement and that the warrant becomes exercisable once stockholders approve the private placement, with an expiration 36 months after the exercise date.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Warrant to Purchase Common Stock | 5,447 | $0.10 | $544.70 |
| Purchase | Common Stock | 6,809 | $5.04 | $34K |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Common stock and warrants were acquired in the Issuer's private placement disclosed in the Current Report on Form 8-K filed with the SEC on January 28, 2026. Reporting person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. The warrant is exercisable upon the Issuer obtaining stockholder approval of the private placement, as required by the Nasdaq rules. The expiration date of the warrant is 36 months after the exercise date.
FAQ
What insider transaction did Cingulate Inc. (CING) report on February 6, 2026?
Who executed the recent Cingulate (CING) stock and warrant purchases?
What are the key terms of the Cingulate (CING) warrants acquired by the LLC?
How does Shane J. Schaffer describe his beneficial ownership of Cingulate (CING) securities?
Were the Cingulate (CING) securities bought in the open market or a private deal?